NCT04149873

Brief Summary

Patients defined with impaired cough function as maximum expiratory pressure (MEP) \< 60cmH2O. Collected the patients in our surgical ICU who are able to reach 6-8CC/IBW under pressure support mode for 24 hours and MEP \< 60cmH2O. Then the patients will be allocated to 3 groups to receive (1) conventional CPT (control group) (2) MI-E (study group A) (3) MI-E plus CPT (study group B) until 48 hours after extubation. Reintubation rates, ICU mortality and post-extubation ICU length of stay will be analyzed to evaluate its effects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
240

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2017

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

January 24, 2018

Completed
1.8 years until next milestone

First Posted

Study publicly available on registry

November 4, 2019

Completed
Last Updated

November 4, 2019

Status Verified

October 1, 2019

Enrollment Period

2.3 years

First QC Date

January 24, 2018

Last Update Submit

October 31, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • mortality rate

    One year mortality rate

    1 year

Study Arms (3)

Control group

PLACEBO COMPARATOR

Control group' has the treatment with \[Physical chest care \]

Procedure: MIE

Experimental group-A

PLACEBO COMPARATOR

'Experimental group-A' has the treatment with \[Mechanical-Insufflation- Exsufflation\]

Procedure: MIE

Experimental group-B

EXPERIMENTAL

'Experimental group-B' has the treatment with \[Mechanical-Insufflation- Exsufflation\] and \[Physical chest care\]

Procedure: MIE

Interventions

MIEPROCEDURE

MIE

Control groupExperimental group-AExperimental group-B

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Written Informed Consent given by the patient or, if not possible, by a legally authorized representative and/or an independent physician as authorized by the competent ethics committee (EC) or independent review board (IRB) and local regulations.
  • To be at least 20 years of age.
  • To be treated in an ICU at the time of enrollment.
  • Endotracheal tube in place
  • The patient is mechanically ventilated and reach:
  • Ventialtopr: Pressure support mode
  • reach 6-8CC/IBW, ideal body weight for 24 hours
  • MEP, maximum expiratory pressure \< 60cmH2O

You may not qualify if:

  • The patient or legally authorized representative refuse
  • \< 20 years of age.
  • Neither endotracheal tube nor mechanical ventilator use
  • The patient is mechanically ventilated, but:
  • The ventialtopr mode NOT: Pressure support mode
  • No reach 6-8CC/IBW, ideal body weight for 24 hours
  • MEP, maximum expiratory pressure \> 60cmH2O
  • Participation as subject in another interventional study within 30 days prior to the first dose of study treatment, or planned participation in such a study during the study or within 30 days of its completion by the patient.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Intensive Care Medicine; Chi Mei Medical Center

Tainan, 710, Taiwan

Location

Study Officials

  • Kuo-Chen Cheng, Chief

    Chi Mei Medical Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 24, 2018

First Posted

November 4, 2019

Study Start

September 1, 2015

Primary Completion

December 31, 2017

Study Completion

December 31, 2017

Last Updated

November 4, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will not share

Locations